Product Information

MOMETASONE FUROATE 0.1% SOLN is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.4622 per ML under NDC 45802011846. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Apr 6, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MOMETASONE FUROATE 0.1% SOLN

Mometasone Furoate
$0.4622per ML

Strength

1 mg/mL

NDC

45802011846

Classification

Generic

Dosage Form

SOLUTION

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

MOMETASONE FUROATE

Approval Type

Generic (ANDA)

FDA Application

ANDA077180

FDA Approved

4/6/2005

TE Code

AB

On Market Since

12/11/2008

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for MOMETASONE FUROATE 0.1% SOLN has been published 678 times since Nov 28, 2013, and over the history we have for it it has risen 97.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4622 per ML
All-time high$0.4777 (Oct 14, 2026)
All-time low$0.1734 (Dec 20, 2017)
52-week high$0.4777
52-week low$0.4344
Median price$0.3138
Average price$0.2964
Largest weekly change-41.5% (Feb 19, 2014)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-2.8%

1M

-3.2%

3M

-3.0%

6M

-0.8%

1Y

+6.4%

3Y

+29.8%

5Y

+55.1%

All

+97.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MOMETASONE FUROATE 0.1% SOLN?

The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 0.1% SOLN, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.4622 per ML (NDC 45802011846), effective Nov 18, 2026.

How has the price of MOMETASONE FUROATE 0.1% SOLN changed over time?

Over the history we have for it, the NADAC for MOMETASONE FUROATE 0.1% SOLN has risen 97.6%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 0.1% SOLN?

Since Nov 28, 2013, the NADAC for MOMETASONE FUROATE 0.1% SOLN has ranged from a low of $0.1734 (Dec 20, 2017) to a high of $0.4777 (Oct 14, 2026), with a median of $0.3138 per ML.

Are there cheaper alternatives to MOMETASONE FUROATE 0.1% SOLN?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MOMETASONE FUROATE 0.1% SOLN, is $0.3672 per ML — about 21% below MOMETASONE FUROATE 0.1% SOLN.

Who manufactures MOMETASONE FUROATE 0.1% SOLN?

MOMETASONE FUROATE 0.1% SOLN (NDC 45802011846) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.